Viewing Study NCT05648968

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2026-02-23 @ 8:47 AM
Study NCT ID: NCT05648968
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2022-11-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Warm Autoimmune Hemolytic Anemia (wAIHA) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None warm autoimmune hemolytic anemia View
None wAIHA View
None ianalumab View
None VAY736 View
None B-cell depletion View
None B-cell Activating Factor Receptor (BAFF-R) blockade View